Psilocybin for stuttering: speech fluency and brain activity study
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests a single dose of psilocybin, a psychedelic compound, to see if it can improve speech fluency and reduce struggle in adults who stutter. It also looks at changes in brain activity using fMRI scans. The study involves preparation sessions, a psilocybin session, and follow-up visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 50 years old.
- You must have a diagnosis of mild-moderate to severe stuttering, confirmed by a specialist.
- You must be able to read, speak, and understand English.
- You must agree to stop taking any non-prescribed drugs or supplements for a period before and after the study.
- You must be willing to use effective birth control if you could become pregnant or get someone pregnant.
- You cannot have certain medical or psychiatric conditions, including heart disease, seizure disorder, severe mental illness, or recent use of psychedelics.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a safe, non-invasive brain stimulation technique called tDCS can help reduce stuttering. It involves attending several sessions where you receive either active stimulation or a placebo, while you speak or do tasks.
This study tests whether very small, repeated doses of psilocybin (a substance found in certain mushrooms) can improve thinking, mood, and quality of life. It is for adults who have never used psychedelics and are in good general health, both mentally and physically.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
This study tests whether psilocybin, a psychedelic drug, combined with therapy can help people reduce or stop drinking. It aims to understand how psilocybin affects the brain and behavior in people with alcohol use disorder.
This trial tests how psilocybin, a psychedelic substance, affects your thinking, memory, and brain activity. Researchers want to understand these effects in healthy adults who have used psychedelics before.
This trial tests whether a medicine called psilocybin (a psychedelic compound) can help people who had a stroke more than a year ago. It aims to see if the therapy can improve healing and flexibility in the brain.
Hear when a new Stuttering trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.